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Our understanding of Na+ homeostasis has recently been reshaped by the notion of skin as a
depot for Na+ accumulation in multiple cardiovascular diseases and risk factors. The pro-
posed water-independent nature of tissue Na+ could induce local pathogenic changes, but
lacks firm demonstration. Here, we show that tissue Na+ excess upon high Na+ intake is a
systemic, rather than skin-specific, phenomenon reflecting architectural changes, i.e. a shift in
the extracellular-to-intracellular compartments, due to a reduction of the intracellular or
accumulation of water-paralleled Na+ in the extracellular space. We also demonstrate that
this accumulation is unlikely to justify the observed development of experimental hyper-
tension if it were water-independent. Finally, we show that this isotonic skin Na+ excess,
reflecting subclinical oedema, occurs in hypertensive patients and in association with aging.
The implications of our findings, questioning previous assumptions but also reinforcing the
importance of tissue Na+ excess, are both mechanistic and clinical.
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In the last decade, the concept of tissue Na
+ shifted the tra-
ditionally nephrocentric view of Na+ homoeostasis to the
interstitium1,2, where the negatively charged glycosaminogly-
cans and a TonEBP/NFAT5-VEGF-c-mediated expansion of the
lymphatic network serve as a depot and draining system for its
accumulation, respectively3–5. The proposed water-independent
nature of this phenomenon6–8 marked its novelty9,10 and its
potential implications in the pathogenesis of hypertension and
cardiovascular disease at large, as independent studies reported a
boosted activation of pathogenic immune-inflammatory cells
upon culture in supraphysiological concentrations of Na+ 11–15.
The translational value of this evidence relies on the presence of
hypertonic (HT) microenvironments in tissues. In humans,
increased tissue Na+ concentration has been identified in asso-
ciation with aging and hypertension16, diabetes17, chronic kidney
disease18 and acute heart failure19 in skin (where the accumula-
tion was initially described as specific in rodent models3,7) and/or
skeletal muscle, as well as in sclerodermic20 or infected skin12, by
means of 23Na-MRI. Excess Na+ accumulation upon salt loading,
with some sex specificities, was also found in healthy subjects by
direct skin chemical analysis21. Importantly, both methods
measure Na+ in the whole tissue. We have previously suggested
that tissue architecture per se can markedly impact on Na+
content and concentration (Fig. 1)22. Such histochemical23,24
considerations are key to conclude on the HT nature of this Na+
excess, which currently lacks demonstration in humans. In fact,
even in rodent models, attempts to isolate hyperosmolar inter-
stitial fluid or lymph proved unsuccessful25. Moreover, the dual
osmotically active and inactive nature of interstitial Na+, driving
TonEBP-mediated signalling while simultaneously eluding par-
allel and commensurate water accrual, appears equivocal. On
these premises, we sought to test the existence, distribution and
putative correlates of HT tissue Na+ accumulation by probative
and disprobative approaches (i.e., by verifying and by assuming
its occurrence, respectively) in preclinical models of and real-life
patients with arterial hypertension.
Our study offers a reappraisal of the tissue Na+ theory, dis-
proves its water-independence in both experimental salt-sensitive
hypertension and hypertensive subjects and suggests systemic
isotonic (IT) Na+ excess as an important player in the patho-
genesis of cardiovascular disease, particularly in association with
the process of aging.
Results
Tissue Na+ accumulation is systemic and isotonic. Male and
female stroke-prone spontaneously hypertensive (SHRSP) and
control Wistar–Kyoto (WKY) rats (12 weeks old) were treated
with 1% NaCl in drinking water (high salt, HS) or normal tap
water (normal salt, NS) for 3 weeks. In males, baseline blood
pressure (BP) was higher, irrespective of strain differences, and
salt sensitivity of BP was confined to SHRSPs (Supplementary
Fig. 1). Skin Na+ content (mmol g−1 of dry weight (DW)) was
increased in SHRSP-HS (+20.7%), as expected; however, we
observed similar increases in tissue Na+ also in liver (+10.3%),
lungs (+14.8%) and skeletal muscle (+23.6%), but not in myo-
cardium (Fig. 2a and Supplementary Data 1). Apart from skeletal
muscle, they were consistently paralleled by increases in tissue
water (skin: +14.1%; liver: +4.8%; lungs: +9.0%) with similar
trends observed for Na+ concentrations (i.e., normalised for
water content, [Na+], mmol L−1; Supplementary Data 1). These
changes upon HS were not observed in WKY rats. A sub-analysis
for males and females showed almost identical patterns (Sup-
plementary Data 1). Different experimental results for tissue Na+
across organs fit well with a prediction model based on the
intracellular/extracellular volume proportion (ECV/ICV) typical
of each tissue (Supplementary Fig. 2a)22,26. Lower water and Na+
between control (NS) strains in skin and liver reflect differences
in fat content that limit the volume of distribution (and total
content, accordingly) of both (Supplementary Fig. 3). Impor-
tantly, K+ concentration ([K+]) showed opposite trends to [Na+]
(Supplementary Data 1). In physiological conditions, the sum of
[K+] and [Na+] in both ECV and ICV is similar, although with
opposite predominance of Na+ and K+, respectively; a mixture of
ECV and ICV in any proportion would still result in a solution of
~140–160 Na++ K+mmol L−1. In all tissues, [Na++ K+] con-
sistently fell within this range, with no differences between strains
or NS/HS allocation (Fig. 2a). Overall, rather than any HT phe-
nomenon, this points to a shift in ECV/ICV ratio and, along with
the concomitant increase observed for tissue water, to systemic
oedema. The difference in the proportional changes of Na+ and
water does not reflect different amounts, as previously suggested,
but different sensitivities to oedema detection (Supplementary
Fig. 2b)22. In fact, water paralleled Na+ content with identical
regression slopes across all groups (Supplementary Fig. 4), except
for skeletal muscle where the water-independent ECV/ICV shift
is likely due to HS-induced sarcopenia27. The lack of oedema in
skeletal muscle and myocardium also reflects the lower physical
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Fig. 1 Histochemical impact of tissue architecture. Intracellular
compartments are rich in K+ (yellow), while extracellular compartments in
Na+ (red); in both, the sum of K+ and Na+ concentrations ([K+] and
[Na+], respectively) is similar. When intracellular and extracellular
compartments are mixed, i.e. a whole tissue chemical analysis is performed,
total [Na+] is higher in any tissue with physiologically less intracellular
volume or undergoing loss of cellularity or oedema accumulation compared
to a reference tissue. The concept applies to 23Na-MRI (bottom), where the
average signal from a voxel is presented as a shade of colour, typically grey
in the commonly used radiological black–white lookup table. ECV
extracellular volume, ICV intracellular volume.
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compliance of these tissues28; of note, in similar experiments
conducted in NS-fed but aged rats (52 weeks old), myocardial
oedema was detectable and accompanied by extracellular matrix
remodelling with an increase in glycosaminoglycans (Supple-
mentary Fig. 5).
The currently proposed mechanistic framework indicates that
water-independent tissue Na+ excess is responsible for a VEGF-c
mediated signalling via TonEBP/NFAT53,4. Although tradition-
ally associated with the response to osmotic stress29, we observed
an increase in TonEBP/NFAT5 expression in skin, lungs and
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Fig. 2 Nature and distribution of tissue Na+ excess and TonEBP expression upon salt loading. Panel a bars: empty=WKY, dashed= SHRSP, red= high
salt (HS) treatment; all bars show mean ± 95% CI, with individual points (overlay; + and x: female and male automatically detected outliers, respectively;
ROUT, Q= 1%); significant differences at predefined comparisons are shown by brackets, on top (two-sided Fisher LSD test; please see also
Supplementary Table 1 for sex-specific data and detailed significance). Tissue Na+ content increased in all tissues in SHRSP-HS, but in myocardium; with
the exception of skeletal muscle, it was consistently paralleled by water accrual. Total Na++ K+ concentration in tissues fell in physiological ranges (light
blue) and was unaffected by salt loading in either strain, ruling out hypertonic accumulations. Panel b data presented as Delta Ct, median ± 95% CI for all
rats; significant differences at two-sided Mann–Whitney test are shown in brackets. Increased TonEBP gene expression followed Na+ and water
accumulation despite no hypertonicity. For both panels, n= 16–18 animals/group, as per Supplementary Data 1; source data are provided as a Source
Data file.
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(borderline significant) liver in SHRSP-HS, as well as in
myocardium of aged SHRSP, despite the lack of hypertonicity
(Fig. 2b and Supplementary Fig. 5). As recently demonstrated for
VSMCs30, we speculate that biomechanical (rather than osmotic)
stress due to oedema accumulation is responsible for the
activation of the lymphangiogenic signal cascade.
Extracellular hypertonic Na+ does not induce hypertensive
vascular dysfunction. Blockade of lymphangiogenesis induces
development of salt-sensitive hypertension3,4. If the resulting
excess tissue Na+ were independent of water (i.e., volume), the
expectation is that it would impact on the other determinant of
hypertension, i.e., peripheral resistance. To test this hypothesis,
we investigated the vascular function of peripheral resistance
arterioles from our NS/HS rats. HS treatment did not result in
hypercontractile responses to U46619 (a thromboxane-receptor
agonist) or KCl but reduced the latter upon repeated stimuli and
the sensitivity to the vasorelaxant effect of nitric oxide (NO) in
SHRSP (Fig. 3 and Supplementary Table 1). Intriguingly, the
concept that vascular swelling could determine increased per-
ipheral resistance and vascular stiffness (to both contraction and
relaxation) in the pathogenesis of hypertension dates back to the
1950s31; although it is supported by subsequent evidence32–34,
which extends to related diseases35 and includes preliminary data
from our rats (Supplementary Fig. 6), it still lacks firm demon-
stration. To test whether an HT environment could directly
induce similar changes, arterioles from NS rats were also pre-
incubated in an IT or HT (+15 mmol L−1 NaCl) solution. Akin
to HS in vivo, HT ex vivo incubation did not affect contractile
responses; however, it induced an opposite shift toward an earlier
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Fig. 3 Impact of in vivo and ex vivo Na+ excess on vascular function of resistance arteries. Panels a, b contractile response to KCl, by strain and
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in vivo HS (LogIC50 to U46619: SHRSP vs.WKY, p < 0.0001, SHRSP-HT vs. SHRSP, p < 0.0001;WKY-HT vs.WKY, p= 0.007); none of these ex vivo effects
would justify an increase in peripheral vascular resistance. Please see Supplementary Table 1a, b for all comparisons; source data are provided as a Source
Data file.
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NO-induced loss of pre-constriction tone in both WKY and
SHRSP (Fig. 3 and Supplementary Table 2).
This is not reminiscent of classic hypertensive vascular
phenotypes and appears more consistent with the neuromuscular
signs of hypernatremia (e.g., lethargy and muscle weakness).
Overall, these data suggest that impaired drainage of tissue Na+ is
unlikely to induce hypertension by directly and adversely modulat-
ing peripheral vascular function in a water-independent manner.
Skin Na+ accumulation in hypertensive patients. To translate
our preclinical findings to humans, we performed a chemical
analysis of arm skin punch biopsies of 76 hypertensive subjects
(Supplementary Table 3). The two anatomically distinct layers of
epidermis/superficial dermis (ESD) and deep dermis (DD) were
analysed separately: as our histochemical approach would predict,
[Na+] and [K+] were lower and higher in the ESD compared to
DD, respectively (Fig. 4a). In virtually no patients, and there-
by in none of the prespecified different clinical subgroups, did
[Na++K+] exceed the physiological value of 155 mmol L−1 in
either layer (Fig. 4b), thus ruling out any HT accumulation. In
both ESD and DD, water content was positively and negatively
correlated with [Na+] and [K+], respectively (Fig. 4c); in DD,
water, Na+ and K+ contents, but not concentrations, were all
positively and highly correlated (Fig. 4c), primarily reflecting their
volume of distribution which excluded dermal fat. Accordingly,
male DD contained more water, Na+ and K+ than female dermis,
which is known to be richer in subcutaneous fat (Supplementary
Fig. 7); no such differences were seen in the ESD (Supplementary
Table 4). Identical histochemical sex differences were observed in
gluteal biopsies from young healthy volunteers (Supplementary
Table 5); notably, fluid-retentive36 progestinic states were
characterised by higher water and Na+ content, but unchanged
[Na++ K+] (Supplementary Fig. 7). In the hypertensive cohort,
age was independently associated with an increase in ESD water
and [Na+], and a decrease in [K+] in both layers (Fig. 4d and
Supplementary Fig. 8); this likely indicates excess fluid accumu-
lation in the context of reduced tissue cellularity, traditionally
accepted as a hallmark of skin aging (Fig. 4d). Salt intake pre-
dicted epidermal water content, but not Na+ or K+, indepen-
dently of age, sex and BMI (Supplementary Fig. 8); at variance
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with aging, the lack of any significant shift in the Na/K ratio in
relation to salt intake would suggest a fluid accumulation evenly
distributed between ICV and ECV. Office diastolic BP was
inversely associated with ESD water content (ρ=−0.250; p=
0.03) and a surrogate of vascular stiffness, pulse pressure (PP),
was positively correlated with Na+/K+ ratios (Fig. 4e); in ESD,
the ratio was higher in patients with uncontrolled BP, indepen-
dent of other covariates. No significant interaction with medica-
tions was observed. NT-proBNP levels, positively associated with
age (ρ= 0.526; p < 0.001), estimated Na+ intake (ρ= 0.260; p=
0.03) and systolic BP (ρ= 0.288; p= 0.01) and negatively with
diastolic BP (ρ=−0.277; p= 0.02), mirrored all measures of skin
oedema accumulation (Fig. 4e). Finally, the lack of correlations
between histochemical skin data and transepidermal water loss
(TEWL)37 (Fig. 4e) stood against the predefined hypothesis that
local regulatory mechanisms could make skin an exception to the
IT nature of systemic tissue Na+ excess/accumulation via a
relative deficit of water.
Discussion
Our study has epistemological, mechanistic, diagnostic and
therapeutic implications. First, while we cannot unconditionally
exclude an HT Na+ accumulation in any tissue milieu or any
clinical/experimental condition, our findings prompt reconsi-
deration of excess tissue Na+ epidemic in light of a simpler
histochemical deductive approach24. Numquam est ponenda
pluralitas sine necessitate38 (plurality is not to be posited without
necessity). Over 80 years ago, Simms and Stolman made cada-
veric observations consistent with our conclusions39. Second, this
concept of tissue Na+ accumulation is not herein disproved but
reinforced and reinterpreted, confirming the importance of reg-
ulatory mechanisms like TonEBP/NFAT5 signalling and lym-
phatic network plasticity in systemic fluid homoeostasis. They
should indeed be a focus for future research, together with the
biophysical/mechanical impact of cellular rarefaction and clini-
cally overt or subclinical oedema, rather than hyperosmotic
niches, on organ function. Third, such foreseeable impact could
be tracked, by non-invasive tissue Na+ analysis, in many relevant
clinical scenarios beyond sole cardiovascular disease. Finally, the
effect of novel natriuretic agents in both prevention and treat-
ment of major cardiovascular events40,41 prompts better identi-
fication of those patients who will benefit most. Considering the
demonstrated potential of these agents in reducing tissue Na+
content3 and the above functional considerations, it is tempting
to speculate that this quest should take into account systemic and/
or organ-specific tissue Na+ analysis.
Methods
Animals. All protocols were performed in accordance with the United Kingdom
Animals Scientific Procedures Act 1986 (Project Licence 70/9021 held by Delyth
Graham) and ARRIVE Guidelines and approved by the institutional ethics review
committee (University Animal Welfare and Ethics Review Board, University of
Glasgow, Glasgow, UK).
We used SHRSP and WKY rats from colonies inbred at the University of
Glasgow since 1991; animals were housed under controlled environmental
temperatures (21 ± 3 °C) and lighting (12-h light–dark cycles).
In the main set of experiments, male and female SHRSP and WKY were
maintained on standard rat diet (rat and mouse No. 1 maintenance diet; Special
Diet Services, Grangemouth, United Kingdom) and provided tap water ad libitum
until 11 weeks of age. At 12 weeks, rats (littermates) were randomised to 1% NaCl
(HS) or normal drinking water (NS) for 3 weeks (n= 8 males/group and n= 10
females/group, except n= 9 female WKY-NS). Systolic BP was measured at
11 weeks of age (baseline) and then monitored weekly by tail-cuff
plethysmography, in an operator-blind fashion whenever possible. In another set of
experiments, male SHRSP and WKY were maintained on standard diet and normal
tap water ad libitum until 20 and 52 weeks of age (WKY 20 weeks n= 10; WKY
52 weeks= 9; SHRSP 20 weeks= 6; SHRSP 52 weeks= 9).
Tissue harvesting and processing. At the end of the 3 weeks of experimental
treatment (main experiment) or at the appropriate age (additional experiment) rats
were euthanized by exsanguination under general terminal isoflurane anaesthesia.
Myocardium (left ventricle), lungs, liver, descending aorta and samples from
shaved abdominal skin and skeletal muscle from the thigh, freed of fascia and
tendon, were dissected and snap-frozen in liquid nitrogen. The dissection time was
kept to a minimum to prevent evaporation of moisture. Any excess blood was
removed by gently blotting the tissues on tissue paper; prior to blotting, heart was
cut into transverse sections and aorta lumen gently washed by gravity with a
phosphate buffer saline-filled syringe. An aliquot from each tissue was cut on the
surgical table and stored into tubes pre-filled with RNA-later (Qiagen Group). All
tissues were stored at −80 °C until use.
From frozen tissue samples, aliquots representative of full parenchyma were cut
and their wet weights (WW) were measured on a four decimal (0.0001 g) electronic
scale (samples WW range= 15–60 μg). To prevent evaporation of tissue water,
cutting was performed in a cold room for all the main set of experiments and
tissues were transported in eppendorf tubes (Sarstedt) in dry ice. Samples were
desiccated at 65 °C in a ThermoMixer (Eppendorf), for >40 h, to a stable DW.
Water content was estimated as (WW−DW)/DW and expressed as mg water/
mgDW, or as water percentage (W%= (WW−DW) × 100/WW). Dried samples
were digested at 65 °C in 20–40 μl of 70% HNO3 (Fisher) for 3 h and, after 1:10 v/v
dilution in deionised water (MilliQ), for 2 additional hours. Digestion blank
controls (i.e., HNO3 and MilliQ only) were prepared and analysed with the
digested samples to confirm the lack of Na+/K+ contaminations. Digested samples
and blanks were centrifuged for 1 min at 16,000 × g and stored at room
temperature; solubilised supernatants were used for Na+ and K+ quantification,
while acid-insoluble residues (present in significant amount in skin and liver
samples) were used for total fat quantification.
Na+/K+ measurement. Na+ and K+ in the digested samples were quantified by
flame photometry (Sherwood scientific, model 410 C). Na+ and K+ calibration
standards of 0–5 ppm (mg/l) were prepared from 1000 ppm solutions (Fisher
Chemical) using HNO3– and milliQ– carefully washed glassware. Before photo-
metric measurements, digested samples were further diluted to fall within the range
of 0–5 ppm. MilliQ was used as the diluent for both standards and samples after
Na+/K+ contamination of HNO3 was excluded on blanks. Na+ and K+ con-
centrations in the digested sample solutions were calculated against the five-points
regression line obtained from the calibration standards. At the calibration used,
reported CV% for reproducibility is <2% (i.e., <0.005 mmol/l for both Na and K in
the measured sample); in our hands CV% was 1.5 intra-sample and 3% inter-
sample (from the same original tissue). Concordance correlation coefficient for
replicated (technical) measurements was 0.98 (Supplementary Fig. 9a); random
duplicate samples from the same stored tissues showed similarly good reproduci-
bility (Supplementary Fig. 9b, c). All samples from the same type of tissue were
analysed in a batch on the same day to minimise technical variability; therefore, few
samples irreversibly affected by experimental issues (e.g., accidentally dropped
sample, contamination, volume shortage) had to be excluded and are reported as
blank cells in the Source Data File. During measurements, blank (diluent) and
calibration standards were checked after every block of approximately eight sam-
ples to control for drift. Na+ and K+ concentrations in the analysed solutions were
used to back-calculate their total content in the digested samples and normalised by
DW for Na+ and K+ tissue content (mmol/gDW), or by tissue water for Na+ and
K+ tissue concentration (mmol/l). During flame photometry analysis, operators
were blind to group allocation of samples.
Fat content analysis. After careful removal of the solubilised material used for
Na+/K+ quantification, total fat was extracted from the acid-insoluble residue of
skin and liver samples in 200 μl of a solvent mixture (chloroform/methanol, 2:1 v/v;
protocol adapted from Lowry et al.24 and Folch et al.42); extraction of the total fat
prevented replication of this specific experiment. After overnight incubation at
room temperature under agitation, solubilised extracts were transferred to pre-
weighed glass tube inserts (Agilent Technologies) and solvents evaporated at 55 °C
to constant weight through repeated SpeedVac cycles. Total fat content in tissues
was normalised by original WW (%WW).
Histology. Sulphated glycosaminoglycans (sGAG) myocardial content was esti-
mated by Alcian Blue staining of available paraffin-embedded transverse mid-
ventricular 5 μm sections from the 20- or 52-week-old WKY and SHRSP male rats
(n= 4–5/group). After deparaffinization (Histoclear) and progressive rehydration
to distilled water, slides were incubated in Alcian Blue solution (1% Alcian Blue
8GX, Sigma, in 3% acetic acid; pH = 2.5) for 20 min, washed in running tap water
for 5 min, rinsed in distilled water and counterstained in Nuclear Fast Red solution
(Vector), washed again in running tap water for 1 min and mounted following
dehydration.
Random, non-consecutive pictures were taken at ×40 from mid-myocardium
(n ≥ 25/animal) and subepicardium (n ≥ 12/animal; immediately below the
epicardial layer) with an Olympus BX41 microscope and dedicated image capture
software. sGAG were quantified as %AlcianBlue+ stained area after standardised
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thresholding across pictures, by use of an in-house developed macro
(Supplementary Note 1) for ImageJ.
TonEBP gene expression analysis. For all tissues, total RNA extraction was
performed using Qiazol (Qiagen) and RNAesy mini-column kit (Qiagen) according
to manufacturer’s guide. For qRT-PCR, CDNA was prepared using the High
capacity CDNA reverse transcription kit (Applied Biosystems) and analysed using
Taqman fast advanced master mix with specific Taqman gene expression assay
probes for TonEBP (Rn01762487_m1), GAPDH (Rn01462661 g1), beta-actin
(Rn00667869 m1). The expression levels were normalised to either GAPDH
(myocardium) or beta-actin (other tissues; housekeeping gene was selected upon
evidence of Ct consistency across groups) and were compared and presented as
delta Ct values (inversely proportional to gene expression level).
Rat vascular function studies. After organ harvesting for tissue chemical/mole-
cular analysis, mesenteries were also dissected from NS/HS WKY and SHRSP rats
and small resistance arteries were isolated as previously described43. Briefly, arterial
segments were mounted on isometric wire myographs (Danish Myo Technology,
Denmark) filled with 5 ml of physiological saline solution (PSS; 119.0 mM NaCl,
4.7 mM KCl, 1.2 mM MgSO4·7H2O, 24.9 mM NaHCO3, 1.2 mM KH2PO4, 2.5 mM
CaCl2 and 11.1 mM glucose) and continuously gassed with a mixture of 95% O2
and 5% CO2 while being maintained at a constant temperature of 37 ± 0.5 °C.
LabChart (ADinstruments) was used for data recording. Following 30 min of
equilibration, baseline tension was normalised as per DMT recommendations and
internal diameter was estimated (https://www.dmt.dk/uploads/6/5/6/8/65689239/
dmt_normalization_guide.pdf); vessels with an internal diameter ≥ 500 μm were
excluded from further analysis. After normalisation, the contractility of arterial
segments was assessed by the addition of KCl (62.5 mmol/L), repeated after 10 min
of washout. The contractile response of vessels from the four experimental groups
to the thromboxane agonist U46619 was tested with concentration-response curves
(10−10 to 3 × 10−6 M); endothelium-independent vasorelaxation was assessed by a
dose–response to the NO-donor sodium nitroprussiate (SNP; 10−10 to 10−5 M),
following pre-constriction with the U46619 dose that produced 75% of the max-
imal contractile response. Other vessels from NS-treated animals were incubated
for 5 h in PSS or in NaCl-supplemented-PSS (+15 mM NaCl, HT) to test the
impact of environmental hypertonicity on vascular function with an ex vivo
approach. Duration and tonicity of the incubations were based on previously
reported tissue changes with HS diet3,4 and effects of HT culture conditions on rat
VSMCs hypertrophy44. After the incubation and one additional KCl stimulation,
concentration-response curves for U46619 and SNP were conducted as described
above. Vessels with no or trivial response to KCL or U46619 pre-constriction were
considered non-viable and their curves were excluded from the analysis.
Human hypertensive subjects. The protocol for the cross-sectional S2ALT (Skin
Sodium Accumulation and water baLance in hypertension) study was approved by
the West of Scotland Research Ethics Committee 3 (ref. 18/WS/0238) and Greater
Glasgow and Clyde NHS Research and Development (ref. GN18CA634). The study
was conducted in compliance with the Declaration of Helsinki. Adult, non-
pregnant patients were recruited from the High BP clinic, Queen Elizabeth Uni-
versity Hospital, Glasgow between March and July 2019. On the day of their
scheduled clinic appointment (9.00 a.m. to 4.30 p.m.), non-pregnant patients
willing to take part gave written, informed consented and had anthropometric
(body height and weight) and routine office BP measures taken as per current
guidelines45; PP was calculated as systolic BP− diastolic BP. Relevant comorbid-
ities and ongoing medications were recorded. On the same occasion we adminis-
tered a short questionnaire to estimate sodium intake, we measured TEWL and we
collected a skin biopsy, serum and EDTA-plasma (for p-Na, p-Urea and p-
Creatinine and for NT-proBNP, respectively) and a random urine sample (for
albuminuria).
Questionnaire. A short, validated questionnaire46 was administered to patients
while waiting for their scheduled visit (Supplementary Note 2). Calculation was
made as reported46. Briefly, it included 42 food items with six possible con-
sumption frequency responses: never; one to three times per week; four to six times
per week; once a day; twice a day; and three plus times a day. Predefined absolute
amounts of sodium per serving size per specific item, according to MRC Food
Composition Tables47 were multiplied by the consumption frequency factor that
each individual reported, and summed up to a total weekly Na+ intake for each
subject, later divided by seven to estimate daily intake. For simplicity, the absolute
amounts of Na per serving for each food category were divided by 50 mg Na+ units
and rounded to the nearest integer46. The frequency factor in the weekly calcu-
lation was taken as the value midway between the upper frequency value of one
category and the lower of the next (i.e., 0, 2, 5, 7, 14, 21).
Missing questionnaire data were missing completely at random (Little’s MCAR
test, p= 0.593). For five subjects, with more than half of the responses missing,
calculations of weekly scores were considered unreliable and excluded. Twenty-two
additional subjects had ≤10% missing responses (10/22 had only 1 missing item):
median substitution was used for imputation and calculation of weekly scores.
Results without imputation were overall identical.
Transepidermal water loss. Before blood collection and skin biopsy and following
a ≥20-min period of acclimatisation in a temperature-controlled environment
(20–21 °C) and ≥5 min of quiet sitting, TEWL37 was assessed from the flexor
portion of the forearm. We used a Tewameter® TM300 probe (Courage & Khazaka
GmbH, Cologne, Germany), which estimates TEWL through two pairs of tem-
perature and humidity sensors and Fick’s diffusion law. Readings were auto-
matically stopped and recorded by an MPA 580 system and dedicated software
when a ≤0.1 standard deviation was reached.
Skin biopsy. Approximately 40 min before the planned biopsy, lidocaine-based
topical anaesthetic cream (LMX4) was applied on the outer upper arm, approxi-
mately halfway between the elbow and shoulder; at variance with other commer-
cially available preparations, this cream was found to be free of any detectable Na+
or K+ content at flame photometry analysis in a pilot study in 18 healthy volun-
teers, used for methods development (SKILLS; University of Glasgow, MVLS
College Ethics Committee, ref. 200160109). After cleaning the skin with cotton
gauze pads and Na+/K+-free 70% alcohol wipes, skin punch biopsies were per-
formed on the anaesthetised site with a disposable instrument (3–4 mm blade
diameter; Kai Medical). The sample was immediately put into a pre-cooled
Eppendorf tube, frozen in dry ice and subsequently stored at −80 °C until tissue
analysis.
Human healthy subjects. A preliminary cross-sectional study on young healthy
volunteers (SOWAS: SOdium and WAter Skin Balance—Insights into Local Reg-
ulation) was approved by the University of Glasgow, MVLS College Ethics Com-
mittee (ref. 200170153) and conducted between July and December 2018. The
study was conducted in compliance with the Declaration of Helsinki. After consent
was obtained, normotension confirmed and comorbidities ruled-out during a
preliminary screening visit, young (19–35 years old) participants recruited among
MVLS students attended a morning visit (starting at 8.00–9.30) after fasting from
midnight. For female participants, the date of the main visit was arranged in the
early follicular phase of their menstrual cycle, just after period termination; in four
cases, due to personal logistics or continuous progesterone treatment (skin
implants or vaginal coil) the main visit coincided with a luteal or luteal-like phase.
During the visit, we measured BP as previously described, we recorded body weight
and bioimpedance-calculated body composition (Tanita, BC-418MA) and collected
serum and EDTA-plasma samples. Sodium excretion on 24 h urine collection,
initiated after the first micturition of the day before and terminated with the first
on the morning of the visit, was assessed semi-quantitatively on site by colorimetric
strips (Salinity View, Health Mate) and later by urinary Na+ quantitation by
ion‑selective electrodes (ISE indirect Na–K–Cl Cobas, Roche Diagnostics GmbH,
Mannheim) to exclude excessively high Na+ consumption (i.e., >5 g/die), con-
firmed for all participants. With an anaesthetic and surgical protocol identical to
what described above, with the exception of the biopsy site, we collected two
adjacent 4 mm punch skin biopsies from the upper external gluteal quadrant. One
of the samples was cut along a sagittal median plane on the bench to symmetrically
include both epidermis and dermis in both halves, immediately put into a pre-
cooled Eppendorf tube, frozen in dry ice and subsequently stored at −80 °C until
tissue analysis.
Human skin samples analysis. Frozen skin samples were macroscopically
transversally cut into a superficial layer, including the epidermis and the imme-
diately adjacent superficial dermis (ESD), and DD layer in a cold room (please see
Supplementary Fig. 7). Tissue processing was identical to what described for rat
tissues, with the exception of a five decimal (0.00001 g) scale (Ohaus, DV214CD)
used for weight measurements due to small size of the samples. Water and Na+/K+
contents were measured as described for rat tissues. The few missing values sec-
ondary to technical issues or insufficient sample were excluded.
Paraffin-embedded samples from the pilot studies mentioned above were used
for histological pictures, representative of sex and age differences. After
deparaffinization (Histoclear) and progressive rehydration, 5 μm sections including
both epidermis and dermis were stained with Picrosirius Red (1 h) or, after
overnight antigen retrieval at 40 °C in Unitrieve (Innovex Biosciences), with
standard DAPI staining protocols.
Statistics. All data were collected in Microsoft Excel spreadsheets. Statistical
analysis was performed using Prism (GraphPad Software) and SPSS (IBM).
Categorical variables are presented as absolute numbers and percentages and
compared by χ2 test. The effect of two factors (e.g., strain and salt load) on different
quantitative response variables in the experimental groups was tested by two-way
ANOVA. For predefined comparisons (e.g., the effect of HS vs. NS) we used Fisher
least-significant-difference test (animals) or Student’s t test (humans) for normally
distributed variables (presented as mean ± SD or, graphically, as mean [95% CI]) or
Mann–Whitney test for non-normally distributed variables (presented as median
[interquartile range] or, graphically, as median [95% CI]). For post hoc
comparisons (e.g., between strains or sexes), labelled as such in the relative figures/
tables, Holm–Sidak test was used. Data tested against a specified value were
analysed by one-sample t-test. Prior to any comparison, outliers were identified by
ROUT method (Q= 1%) and excluded from analysis but reported on the relative
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figures. Regression curves were derived by least-square method and compared by
Extra sum-of-squares F test; for vascular function analysis, maximal contraction/
relaxation and (Log)EC50/IC50 were independently compared. Correlations were
ascertained by Pearson test, upon appropriate transformation of skewed variables
to attain normal distribution. Univariable and multivariable (including age, sex,
BMI and estimated Na intake) linear regression models were used and results were
presented as standardised B coefficients (95% CI). The α level was set at 0.05 and all
statistical tests were two tailed (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001).
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
The authors declare that all data supporting the findings of this study are available within
the paper and its supplementary information. Source data are provided with this paper.
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